Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
advocacy, aforementioned, AgreementSM, Article, attached, binding, BioMed, book, burdensome, Castle, CAT, centric, CHMP, clause, Cogent, Columbia, compliant, contact, correction, Council, County, COVID, Crescent, criterion, CTR, cultivate, Database, dialogue, dollar, dossier, EC, EMA, Fairmount, flexibility, Harbour, Harmonization, Helsinki, hit, home, Humer, ICH, ID, inflation, Inline, interplay, Kristian, lawsuit, Leerink, meaningfully, mission, NCA, Obama, obviating, Orange, orderly, outsourced, outsourcing, overhaul, pediatric, penalty, pharmacovigilance, PhRMA, PIP, plc, portal, procedure, rapporteur, recession, requisite, SAWP, simplify, slightly, SmPC, standing, steady, striving, sublease, substance, sunset, suspected, TCA, uncapped, underwritten, undisclosed, unified, vacated, Valenza, war, whichever, Wilmington
Removed:
abnormal, accounted, accumulation, billed, Blueprint, body, branch, building, cancer, chemotherapy, collaborate, collateral, commitment, composition, continual, continuously, creation, customary, discount, domestic, enrolled, estimating, fourth, gap, immaterial, implanted, incentivize, ineffective, infused, inhaled, injected, instilled, Jason, leading, Leverone, listing, Lookout, MAA, minimizing, modulate, noncancelable, path, pertaining, pocket, profit, prolonged, qui, refuse, region, resell, residency, Road, safeguarding, scar, serving, shareholder, sharing, Shield, soliciting, transmission, treasurer, Trump, whistleblower
Filing tables
Filing exhibits
Related press release
Associated VRDN transcripts
VRDN similar filings
Filing view
External links
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-251367 and 333-260859) on Form S-3 and (Nos. 333-216112, 333-223672, 333-230271, 333-237165, 333-250906 and 333-254771) on Form S-8 of our report dated March 11, 2022 with respect to the consolidated financial statements of Viridian Therapeutics, Inc.
/s/ KPMG LLP
Boulder, Colorado
March 11, 2022